The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gafarov V.V.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

Gromova E.A.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

Shakhtshneider E.V.

Research Institute for Therapy and Preventive Medicine — branch of the Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences

Tripelgorn A.N.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences

Gagulin I.V.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

Gafarova A.V.

Research Institute of Therapy and Preventive Medicine — branch of the Institute of Cytology and Genetics Siberian Branch of the Russian Academy of Sciences;
Collaborative Laboratory of Epidemiology of Cardiovascular Diseases

Association of sleep disorders with APOE gene polymorphisms among the residents aged 25—64 years of the Novosibirsk city: WHO «MONICA psychosocial study»

Authors:

Gafarov V.V., Gromova E.A., Shakhtshneider E.V., Tripelgorn A.N., Gagulin I.V., Gafarova A.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(5): 75‑81

Read: 1018 times


To cite this article:

Gafarov VV, Gromova EA, Shakhtshneider EV, Tripelgorn AN, Gagulin IV, Gafarova AV. Association of sleep disorders with APOE gene polymorphisms among the residents aged 25—64 years of the Novosibirsk city: WHO «MONICA psychosocial study». Russian Journal of Preventive Medicine. 2025;28(5):75‑81. (In Russ.)
https://doi.org/10.17116/profmed20252805175

Recommended articles:
Asso­ciation of adipokines and sleep diso­rders among the 25—44 year-old people. Russian Journal of Preventive Medi­cine. 2025;(8):41-47
Sleep diso­rders in imprinting diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):75-80
The effect of sleep and other medi­cal and social factors on a woman’s reproductive function. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):81-86
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Sleep diso­rders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132
The place of physiotherapy in non-pharmacological treatment of inso­mnia: modern concepts. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(4):36-46

References:

  1. Cormier RE. Sleep Disturbances. In: Walker HK, Hall WD, Hurst JW, eds. Clinical Methods: The History, Physical, and Laboratory Examinations. 3th edition. Boston: Butterworths; 1990. Chapter 77. Accessed March 11,2025. https://www.ncbi.nlm.nih.gov/books/NBK401/
  2. Gafarov VV, Gromova EA, Gagulin IV, et al. Sleep disorders and the risk of myocardial infarction and stroke in men of Novosibirsk. Rossijskij kardiologicheskij zhurnal. 2014;(9):43-47. (In Russ). https://doi.org/10.15829/1560-4071-2014-9-43-47
  3. Gafarov VV, Gromova EA, Gagulin IV, et al. Kabanov YuN, Gafarova AV. Sleep disturbances and 14-year risk of hypertension in 25—64 years old males (an epidemiological study based on the who program « MONICA -psychosocial»). Arterial Hypertension. 2009;15(4):431-435. (In Russ.). https://doi.org/10.18705/1607-419X-2009-15-4-431-435
  4. Gafarov VV, Panov DO, Gromova EA, et al. Sleep disorders and risk of arterial hypertension and stroke in an open population among women aged 25—64 years in Russia/Siberia (population study — WHO program «MONICA-psychosocial»). Kardiovaskuljarnaja terapija i profilaktika. 2017;16(5):86-90. (In Russ.). https://doi.org/10.15829/1728-8800-2017-5-86-90
  5. Gafarov VV, Gromova EA, Panov DO, et al. Dynamics of sleep duration (2003—2018) and the risk of myocardial infarction in an open population aged 45—64 in Russia/Siberia. Rossijskij kardiologicheskij zhurnal. 2022;27(5):4943. (In Russ.). https://doi.org/10.15829/1560-4071-2022-4943
  6. Chung J, Goodman M, Huang T, et al. Multi-dimensional sleep and mortality: The Multi-Ethnic Study of Atherosclerosis. Sleep. 2023;46(9):zsad048. https://doi.org/10.1093/sleep/zsad048
  7. Gafarov VV, Gagulin IV, Gromova EA, et al. Depression, anxiety and sleep disorders in the population aged 45—69 years in Russia (Siberia): an epidemiological study. Nevrologija, nejropsihiatrija, psihosomatika. 2017;9(4):31-37. (In Russ.). https://doi.org/10.14412/2074-2711-2017-4-31-37
  8. Alqurashi YD, AlHarkan K, Aldhawyan A, et al. Risk of Obstructive Sleep Apnea and its Relation to Cognitive Functions among Saudi Older Adults. Medical Archives. 2024;78(1):51-54.  https://doi.org/10.5455/medarh.2024.78.51-54
  9. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377.  https://doi.org/10.1126/science.1241224
  10. Insel PS, Hansson O, Mattsson-Carlgren N. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults without Cognitive Impairment. JAMA Neurology. 2021;78(2):229-235.  https://doi.org/10.1001/jamaneurol.2020.3780
  11. Kunkle BW, Grenier-Boley B, Sims R, et al.; Alzheimer Disease Genetics Consortium (ADGC). Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nature Genetics. 2019;51(3):414-430.  https://doi.org/10.1038/s41588-019-0358-2
  12. Suhanov AV, Pilipenko PI, Korczyn AD, et al. Risk factors for Alzheimer’s disease in Russia: a case-control study. European Journal of Neurology. 2006;13(9):990-995.  https://doi.org/10.1111/j.1468-1331.2006.01391.x
  13. Sukhanov AV, Denisova DV, Maksimov VN, et al. The influence of the APOE gene polymorphism on the state of cognitive functions in individuals aged 14—17 and 25—44 years. Ateroskleroz. 2023;19(3):316-318. (In Russ.). https://doi.org/10.52727/2078-256X-2023-19-3-316-318
  14. Therriault J, Benedet AL, Pascoal TA, et al.; Alzheimer’s Disease Neuroimaging Initiative. APOEε4 potentiates the relationship between amyloid-β and tau pathologies. Molecular Psychiatry. 2021;26(10):5977-5988. https://doi.org/10.1038/s41380-020-0688-6
  15. Hita-Yanez E, Atienza M, Gil-Neciga E, et al. Disturbed sleep patterns in elders with mild cognitive impairment: the role of memory decline and ApoE ε4 genotype. Current Alzheimer Research. 2012;9(3):290-297.  https://doi.org/10.2174/156720512800107609
  16. Spira AP, An Y, Peng Y, et al. APOE Genotype and Nonrespiratory Sleep Parameters in Cognitively Intact Older Adults. Sleep. 2017;40(8):zsx076. https://doi.org/10.1093/sleep/zsx076
  17. Kahya M, Vidoni E, Burns JM, et al. The relationship between Apolipoprotein ε4 carrier status and sleep characteristics in cognitively normal older adults. Journal of Geriatric Psychiatry and Neurology. 2017;30(5):273-279.  https://doi.org/10.1177/0891988717720301
  18. Drogos LL, Gill SJ, Tyndall AV, et al. Evidence of association between sleep quality and APOE ε4 in healthy older adults: A pilot study. Neurology. 2016;87(17):1836-1842. https://doi.org/10.1212/WNL.0000000000003255
  19. Kadotani H, Kadotani T, Young T, et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA. 2001;285(22): 2888-2890. https://doi.org/10.1001/jama.285.22.2888
  20. Gottlieb DJ, DeStefano AL, Foley DJ, et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology. 2004;63(4):664-668.  https://doi.org/10.1212/01.wnl.0000134671.99649.32
  21. Blackman J, Love S, Sinclair L, et al. APOE ε4, Alzheimer’s disease neuropathology and sleep disturbance, in individuals with and without dementia. Alzheimer’s Research and Therapy. 2022;14(1):47.  https://doi.org/10.1186/s13195-022-00992-y
  22. Thakre TP, Mamtani MR, Kulkarni H. Lack of association of the APOE epsilon 4 allele with the risk of obstructive sleep apnea: meta-analysis and meta-regression. Sleep. 2009;32(11):1507-1511. https://doi.org/10.1093/sleep/32.11.1507
  23. Lim AS, Yu L, Kowgier M, et al. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurology. 2013;70(12):1544-1551. https://doi.org/10.1001/jamaneurol.2013.4215
  24. World Health Organization. MONICA Psychosocial Optional Study. Suggested Measurement Instruments. Copenhagen: WHO Regional Office for Europe; 1988.
  25. Sambrook J, Russel DW. Purification of nucleic acids by extraction with phenol:chloroform. CSH Protocols. 2006;1:pdb.prot4455. https://doi.org/10.1101/pdb.prot4455
  26. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8(1):1-21.  https://doi.org/10.1161/01.atv.8.1.1
  27. Das HK, McPherson J, Bruns GA, et al. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. Journal of Biological Chemistry. 1985;260(10):6240-6247.
  28. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. Journal of Lipid Research. 1990;31(3):545-548. 
  29. Bühl A, Zöfel P. SPSS Version 10. Einführung in Die Moderne Datenanalyse unter Windows. 2005.
  30. Fallaize R, Carvalho-Wells AL, Tierney AC, et al. APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome. Scientific Reports. 2017;7(1):6274. https://doi.org/10.1038/s41598-017-05802-2
  31. Martínez-Martínez AB, Torres-Perez E, Devanney N, et al. Beyond the CNS: The many peripheral roles of APOE. Neurobiology of Disease. 2020; 138:104809. https://doi.org/10.1016/j.nbd.2020.104809
  32. Yesavage JA, Friedman L, Kraemer H, et al. Sleep/Wake Disruption in Alzheimer’s Disease: APOE Status and Longitudinal Course. Journal of Geriatric Psychiatry and Neurology. 2004;17:20-24.  https://doi.org/10.1177/0891988703261994
  33. Korostovtseva L, Alieva A, Rotar O, et al. Sleep Duration, Lipid Profile and Insulin Resistance: Potential Role of Lipoprotein(a). International Journal of Molecular Sciences. 2020;21(13):4680. https://doi.org/10.3390/ijms21134680
  34. Klei L, Reitz P, Miller M, et al. Heritability of Morningness-Eveningness and Self-Report Sleep Measures in a Family-Based Sample of 521 Hutterites. Chronobiology International. 2005;22:1041-1054. https://doi.org/10.1080/07420520500397959
  35. Kripke DF, Shadan FF, Dawson A, et al. Genotyping sleep disorders patients. Psychiatry Investigation. 2010;7:36-42.  https://doi.org/10.4306/pi.2010.7.1.36
  36. Pellegrino R, Mazzotti DR, Guindalini C, et al. Apolipoprotein E polymorphisms and sleep quality in Obstructive Sleep Apnea Syndrome. Clinica Chimica Acta. 2011;412:2223-2227. https://doi.org/10.1016/j.cca.2011.08.007
  37. Yang L, Ma L, Guo W, et al. Interaction of polymorphisms in APOA4-APOA5-ZPR1-BUD13 gene cluster and sleep duration on 5-year lipid changes in middle aged and older Chinese. Sleep. 2019;42:1-9.  https://doi.org/10.1093/sleep/zsz115
  38. Hwang JY, Byun MS, Choe YM, et al. Moderating effect of APOE ε4 on the relationship between sleep-wake cycle and brain β-amyloid. Neurology. 2018;90:e1167-e1173. https://doi.org/10.1212/WNL.0000000000005193
  39. Tranah GJ, Yaffe K, Nievergelt CM, et al; Osteoporotic Fractures in Men Study (MrOS) Research Group. APOEε4 and slow wave sleep in older adults. PLoS One. 2018;13(1):e0191281. https://doi.org/10.1371/journal.pone.0191281
  40. Yesavage JA, Friedman L, Kraemer H, et al. Sleep/Wake Disruption in Alzheimer’s Disease: APOE Status and Longitudinal Course. Journal of Geriatric Psychiatry and Neurology. 2004;17:20-24.  https://doi.org/10.1177/0891988703261994
  41. Ju YE, McLeland JS, Toedebusch CD, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurology. 2013;70(5):587-593.  https://doi.org/10.1001/jamaneurol.2013.2334
  42. Tabuchi M, Lone SR, Liu S, et al. Sleep interacts with aβ to modulate intrinsic neuronal excitability. Current Biology. 2015;25(6):702-712.  https://doi.org/10.1016/j.cub.2015.01.016
  43. Sprecher KE, Bendlin BB, Racine AM, et al. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Neurobiology of Aging. 2015;36(9):2568-2576. https://doi.org/10.1016/j.neurobiolaging.2015.05.004
  44. Palpatzis E, Bass N, Jones R, et al. Longitudinal association of apolipoprotein E and sleep with incident dementia. Alzheimer’s and Dementia. 2022;18(5):888-898.  https://doi.org/10.1002/alz.12439

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.